0001209191-20-013039.txt : 20200226
0001209191-20-013039.hdr.sgml : 20200226
20200226163923
ACCESSION NUMBER: 0001209191-20-013039
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200224
FILED AS OF DATE: 20200226
DATE AS OF CHANGE: 20200226
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tatsis Ourania
CENTRAL INDEX KEY: 0001789815
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 20656362
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS, INC.
STREET 2: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-02-24
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001789815
Tatsis Ourania
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
SVP, CRO
Common Stock
2020-02-24
4
F
0
1036
239.23
D
14034
D
Common Stock
2020-02-25
4
S
0
416
229.57
D
13618
D
Common Stock
2020-02-25
4
S
0
160
231.82
D
13458
D
Common Stock
2020-02-25
4
S
0
80
232.43
D
13378
D
Common Stock
2020-02-25
4
S
0
240
234.43
D
13138
D
Common Stock
2020-02-25
4
S
0
160
235.39
D
12978
D
Common Stock
2020-02-25
4
S
0
240
237.81
D
12738
D
Transaction made pursuant to Ms. Tatsis' company-approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $229.57 (range $229.15 to $229.91).
Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $231.82 (range $231.27 to $232.37).
Open market sales reported on this line occurred at a weighted average price of $234.43 (range $234.14 to $234.89).
Open market sales reported on this line occurred at a weighted average price of $235.39 (range $235.33 to $235.44).
Open market sales reported on this line occurred at a weighted average price of $237.81 (range $237.24 to $238.18).
/s/ Omar White, Attorney-in-Fact
2020-02-26